L3VLUP
ProSign in

NVAX · AMGN in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

NVAXAMGN
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • NVAX
  • AMGN
0102030202120222023202420252026
Holders and value by quarter
QuarterNVAXAMGN
Q3 20206 holders, $258m16 holders, $16.3bn
Q4 20204 holders, $221m19 holders, $14.0bn
Q1 202110 holders, $1.5bn16 holders, $14.5bn
Q2 20218 holders, $1.6bn23 holders, $13.8bn
Q3 20214 holders, $609m24 holders, $11.6bn
Q4 20214 holders, $399m21 holders, $10.4bn
Q1 20225 holders, $121m23 holders, $9.9bn
Q2 20226 holders, $148m28 holders, $9.7bn
Q3 20223 holders, $34m21 holders, $7.9bn
Q4 20223 holders, $8.0m24 holders, $9.3bn
Q1 20232 holders, $12m22 holders, $8.4bn
Q2 20231 holders, $7.7m26 holders, $7.4bn
Q3 2023none listed holders, n.a.26 holders, $8.7bn
Q4 20231 holders, $7.3m24 holders, $8.4bn
Q1 20242 holders, $13m25 holders, $6.7bn
Q2 20246 holders, $163m20 holders, $8.0bn
Q3 20245 holders, $129m21 holders, $8.8bn
Q4 20242 holders, $520k20 holders, $8.2bn
Q1 20252 holders, $25m25 holders, $12.0bn
Q2 20252 holders, $24m20 holders, $10.2bn
Q3 20252 holders, $40m17 holders, $10.4bn
Q4 20251 holders, $1.3m19 holders, $18.0bn
Q1 20262 holders, $31m15 holders, $21.4bn
Q2 20261 holders, $36m23 holders, $24.9bn
NVAX

Novavax Inc

Holders
2
Reported value
$24m
Buyers
0
Sellers
0

Breadth 0 among 95 comparable managers.

Pharmaceuticals and biotechnologyBiological productsHealthcare: biopharma and medtech · L3VLUP
AMGN

Amgen Inc

Holders
20
Reported value
$10.2bn
Buyers
13
Sellers
8

Breadth +5 among 95 comparable managers.

Pharmaceuticals and biotechnologyBiological productsHealthcare: biopharma and medtech · L3VLUP

Who holds both, Q2 2025

Among the 22 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Both (0)

No tracked manager lists every one of them.

Only NVAX (2)

Coatue Management LLC, Farallon Capital Management LLC

Only AMGN (20)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, ARK Investment Management LLC, Arrowstreet Capital LP, Brevan Howard Capital Management LP, Bridgewater Associates LP, Capital Research Global Investors, Capital World Investors, D. E. Shaw & Co., Dodge & Cox, Fidelity (FMR LLC), Invesco Ltd, Janus Henderson Group Ltd, Man Group PLC, Neuberger Berman Group LLC, Renaissance Technologies LLC, T. Rowe Price Associates Inc, Tudor Investment Corp, Woodline Partners LP

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →